LivaNova

$77.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.84 (+1.10%) Today
$0.00 (0.00%) As of 11:00 PM UTC after-hours

Why Robinhood?

You can buy or sell LivaNova and other stocks, options, and ETFs commission-free!

About LIVN

LivaNova PLC Ordinary Shares, also called LivaNova, is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the following segments: Cardiovascular and Neuromodulation. The Cardiovascular segment develops, produces, and sells cardiopulmonary products, heart valves, and advanced circulatory support products. The Neuromodulation segment designs and markets NM-based medical devices for the treatment of epilepsy, depression, and obstructive sleep apnea. The company was founded on February 20, 2015 and is headquartered in London, the United Kingdom. The listed name for LIVN is LivaNova PLC Ordinary Shares.

CEO
Damien McDonald
Employees
4,000
Headquarters
London, Greater London
Founded
2015
Market Cap
3.75B
Price-Earnings Ratio
Dividend Yield
Average Volume
741.69K
High Today
$79.12
Low Today
$76.02
Open Price
$77.29
Volume
625.66K
52 Week High
$79.12
52 Week Low
$33.40

LIVN News

BenzingaFeb 24

LivaNova: Q4 Earnings Insights

Shares of LivaNova (NASDAQ:LIVN) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share fell 29.00% over the past year to

LIVN Earnings

-$0.30
$0.13
$0.57
$1.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
$0.66 per share
Actual
$0.71 per share
Replay Earnings Call

You May Also Like

RYE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure